SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

The market is experiencing significant volatility as investors digest a contentious presidential address regarding ongoing geopolitical tensions in the Middle East, leading to conflicting reactions from bulls hoping for stability and bears anticipating further downside. Community discourse is currently dominated by intense frustration over market manipulation, with active debate centered on whether the recent price swings are driven by genuine geopolitical threats or tactical, news-driven trading patterns.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is gaining significant community momentum as it approaches its one-year anniversary and the 4/20 holiday, with participants highlighting its organic culture and focus on decentralizing cannabis-related utility. Investors and enthusiasts are actively discussing the project's long-term stability and its unique role in merging blockchain technology with the global cannabis movement.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is capturing investor attention as the AI hardware sector navigates high-stakes geopolitical tensions and volatility surrounding U.S. policy in the Middle East. While community sentiment remains split between bullish long-term conviction in AI infrastructure dominance and bearish concerns over potential short-term pullbacks, traders are intensely focused on how upcoming policy updates will impact the stock's stability.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is currently experiencing high volatility driven by geopolitical tensions in the Middle East and market speculation regarding a high-stakes presidential address. Community discourse remains deeply polarized, with traders debating whether the asset will break through resistance levels or succumb to a broader market sell-off.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is seeing intense market volatility driven by a convergence of speculative catalysts, including the high-stakes SpaceX IPO filing and the anticipation of Q1 delivery figures. Investors are currently weighing a potential 'halo effect' from the Musk ecosystem against broader concerns over demand, manufacturing costs, and the company's valuation relative to traditional automotive metrics.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amidst intense community debate surrounding a recent high-profile speech regarding the conflict in Iran, which has fueled widespread speculation about the company's financial future and its leader's political and mental fitness. Users are heavily divided, with supporters touting the administration's military strategy while critics, including vocal skeptics and short-sellers, flood the ticker with concerns over potential market volatility, geopolitical instability, and accusations of corporate mismanagement.

Applied Digital Corporation

Applied Digital is currently navigating extreme volatility as investors weigh the stock's long-term growth potential against broader macroeconomic fears and ongoing geopolitical uncertainty surrounding the Iran conflict. While the community remains deeply divided between long-term bulls highlighting robust AI infrastructure demand and skeptical traders wary of debt concerns, active discussions are intensely focused on upcoming earnings and potential hyperscaler lease announcements as critical catalysts for a rebound.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending due to reports that Amazon is in advanced talks to acquire the company to bolster its satellite internet ambitions and compete with Starlink, sparking widespread community debate over a potential bidding war involving Apple and SpaceX. Investors are actively discussing the implications of Amazon's reported interest, potential buyout valuations, and whether Globalstar's strategic spectrum assets could trigger a broader consolidation in the satellite sector.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is seeing intense activity driven by its recent quarterly earnings report, which highlighted massive revenue growth, alongside ongoing market speculation regarding Middle Eastern oil supply disruptions. Investors and community members are actively debating the stock's potential for a short squeeze due to high borrowing costs and low share availability, while sentiment remains polarized between those holding for a long-term energy play and those cautioning against potential volatility.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently surging on high momentum as market speculation around a major SpaceX IPO acts as a powerful catalyst for the entire aerospace sector. Investors are actively debating whether this sector-wide rally will lead to a sustained breakout for Rocket Lab or if the hype cycle will ultimately result in a liquidity shift toward newer public offerings.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Alto will now focus on its other programs including ALTO-207 in development for treatment -resistant depression.</li><li>The company said that it also intends to explore partnering opportunities for a modified-release oral formulation of ALTO-101 that it has developed.</li></ul>Shares of Alto Neuroscience, Inc. (ANRO) fell as much as 10% after hours on Wednesday after the company said that its experimental drug for the treatment of schizophrenia failed to achieve statistical significance on key goals in a mid-stage study.The company was studying ALTO-101 for the treatment of cognitive impairment associated with schizophrenia. However, no statistically significant changes were detected on primary electroencephalography or cognitive endpoints as compared to placebo, the company said.<h2 class="st-heading-2">Plans Ahead</h2>As a result, the company does not intend to independently advance ALTO-101 in CIAS anymore, it said, while adding that it would now focus on its other programs including ALTO-207 in development for treatment -resistant depression. Alto is looking to initiate a mid-stage trial for &nbsp;ALTO-207 in the first half of 2026. &nbsp;The company said that it now intends to explore partnering opportunities for a modified-release oral formulation of ALTO-101 that it has developed. The formulation has demonstrated an improved pharmacokinetic and tolerability profile when compared to the immediate-release formulation, Alto said, while adding that it believes the formulation may offer potential benefits across several therapeutic areas.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around ANRO &nbsp;stayed within the ‘bearish’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘high’ levels.A Stocktwits user noted the company’s balance sheet, terming it an “easy short.”<stembedurl>https://www.stocktwits.com/Shortski/message/649224122</stembedurl>The company said earlier this month that it had cash, cash equivalents, and restricted cash of approximately $177 million as of the end of 2025, expected to support its planned operations into 2028.Another user termed the selloff an “overreaction.”<stembedurl>https://www.stocktwits.com/RazorbackAJ/message/649224026</stembedurl> <a href="https://stocktwits.com/symbol/ANRO">ANRO stock</a> has gained 32% this year.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-agpu-stock-rise-today/cZ7HyVtRIF0">Why Did AGPU Stock Rise 120% Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Alto Neuroscience logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

ANRO Stock Falls After Hours On Failed Schizophrenia Study Results

Alto Neuroscience does not intend to independently advance ALTO-101 in CIAS anymore, it said. 

Equity

<ul class="summary-bullets"><li>New Era Energy added that the TCDC project is expected to be structured through a newly formed Delaware limited liability company.</li><li>The project’s financing will be led by an unnamed institutional investor, with debt accounting for about 80% of the funding, it said.</li><li>New Era Energy stated that its equity position in the venture is expected to generate distributions from operating cash flow after commercial operations of the first phase commence.</li></ul>New Era Energy &amp; Digital Inc. (NUAI) shares gained nearly 6% in Wednesday’s opening trade after the company announced a partnership for its flagship Texas data center facility.New Era Energy stated that it has entered into a non-binding letter of intent (LOI) to form a joint venture with Stream Data Centers for the development and financing of the company’s Texas Critical Data Centers (TCDC) facility in West Texas.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/NUAI">New Era Energy</a> trended in the ‘bearish’ territory at the time of writing.<h2 class="st-heading-2">Stream To Develop And Manage NUAI’s Facility</h2>New Era Energy stated that Stream will develop and manage the company’s data center facility, while leveraging the former’s local relationships.It added that the TCDC project is expected to be structured through a newly formed Delaware limited liability company. The project’s financing will be led by an unnamed institutional investor, with debt accounting for about 80% of the funding.The company added that its equity position in the venture is expected to generate distributions from operating cash flow after commercial operations of the first phase commence, providing a near-term path to recurring revenue.“This LOI represents an important step in advancing TCDC toward delivery, and we remain focused on progressing toward a definitive agreement with Stream,” said New Era Energy CEO E. Will Gray II.He added that the company expects to invest in the project alongside its partner amid a growing need for purpose-built, power-ready data center infrastructure.<h2 class="st-heading-2">TCDC Campus Spread Across 438 Acres</h2>New Era Energy’s TCDC campus is located in the Permian Basin of West Texas. The campus is spread across 438 acres owned by the company, with an additional 54-acre corridor that is currently pending approval.The TCDC campus is designed for a total capacity of over a gigawatt, with the expansion planned across three phases. The first phase will kick off with 200 megawatt capacity, while the second phase will add another 450 MW capacity. New Era Energy states that it will utilize utility-sourced power and on-site gas-fired energy in these two phases.The third phase is expected to take the total capacity to over a gigawatt. The company has projected that power delivery will be achieved by the end of 2027.In January 2026, New Era Energy&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-nuai-stock-falling-today/cmyR4nVR4gX">announced</a> plans to raise up to $350 million to fund acquisitions, pay or refinance debt, meet capital expenditures, and other working capital requirements.<h2 class="st-heading-2">How Did Retail Traders React?</h2>One user stated that the partnership announced on Wednesday removes one of the biggest question marks for the company going forward.<stembedurl>https://stocktwits.com/roiger/message/649150963</stembedurl>Another user stated that this is big news for New Era Energy, adding that the company is “completely derisked now.”<stembedurl>https://stocktwits.com/YoloAlfred/message/649150643</stembedurl><a href="https://stocktwits.com/symbol/NUAI">NUAI stock</a> is up 39 % year-to-date and 256% over the past 12 months. The Vanguard Total Stock Market Index Fund ETF (VTI) is up 17% over the past 12 months, while the Vanguard Extended Market Index Fund ETF (VXF) is up 20%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nke-stock-tumbles-q4-outlook-china-weakness-nike-stock-downgrade-pt-cuts/cZ7HkFpRInM">Nike’s China Bet Is Under Pressure And Wall Street Is Losing Confidence – Analysts Warn Return To Growth Could Take 4 Quarters</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Computer racks in Data Center (Representative image courtesy of Arctic-Images via Getty Images)

Why Is NUAI Stock Rising Today? A Texas Data Center Deal Could Be Key

New Era Energy stated that it has entered into a non-binding letter of intent to form a joint venture with Stream Data Centers to develop and finance the facility.

<ul class="summary-bullets"><li>Nike CEO Elliott Hill stated that the company’s turnaround strategy in Greater China is still in its early stages of a comeback, while adding that the efforts are taking longer to fructify than he would like.</li><li>Analysts on Wall Street expressed concerns with Nike’s turnaround efforts, warning that a return to growth could take as long as four more quarters.</li><li>Goldman Sachs stated that it is “incrementally cautious” with respect to Nike’s timeline of recovery following the Q3 results, while highlighting that the Chinese market is under “particular pressure.”</li></ul>Nike Inc. (NKE) shares tanked more than 11% in Wednesday’s pre-market trade, on track to fall to a low of more than 11 years after the company’s fourth-quarter (Q4) guidance fell short of Wall Street expectations.Nike&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nike-stock-tumbles-toward-9-year-low-retail-traders-shrug-off-soft-outlook/cZ7HhpHRInK">expects</a> Q4 revenue to decline between 2% and 4% year-on-year (YoY), implying a range of $10.66 billion and $10.88 billion. This is lower than the consensus estimate of $11.3 billion, according to Fiscal.ai data.After a 7% decline in sales in the Chinese market in the third quarter (Q3), Nike said it expects a 20% decline in Q4.Nike CEO Elliott Hill stated that the company’s turnaround strategy in Greater China is still in its early stages of a comeback, while adding that the efforts are taking longer to fructify than he would like.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/NKE">Nike</a> trended in the ‘extremely bullish’ territory at the time of writing, with message volumes at ‘extremely high’ levels.<h2 class="st-heading-2">Wall Street Concerned</h2>Analysts on Wall Street expressed concerns with Nike’s turnaround efforts, warning that a return to growth could take as long as four more quarters.According to TheFly, JPMorgan downgraded Nike to ‘Neutral’ from ‘Overweight’, while lowering the price target to $52 from $86. The firm flagged the time-consuming turnaround efforts, while trimming fiscal 2027 and 2028 earnings estimates below the consensus.Goldman Sachs analysts downgraded Nike to ‘Neutral’ from ‘Buy’, while slashing the price target to $52 from $76. The firm stated that it is “incrementally cautious” about Nike’s recovery timeline following the Q3 results, while noting that the Chinese market is under “particular pressure.”Barclays trimmed its price target for NKE stock to $67 from $73 while maintaining an ‘Overweight’ rating. The firm highlighted the slow speed of the Greater China reset, adding that it is “likely to take four quarters to return to growth.”Piper Sandler analysts noted that Nike’s guidance for flat earnings per share (EPS) over the next nine months was significantly below expectations. The firm trimmed its price target for Nike to $60 from $75 while keeping an ‘Overweight’ rating.<h2 class="st-heading-2">How Did Retail Traders React?</h2>NKE was the top trending ticker on Stocktwits at the time of writing.One user highlighted that people can barely afford groceries and the sky-high gas prices, while asking where the buyers are for a $220 pair of Air Jordans.<stembedurl>https://stocktwits.com/Terrordomo80/message/649147628</stembedurl>Another user stated that while they were buying Nike shoes at one point, they have now switched to Asics.<stembedurl>https://stocktwits.com/lecagot/message/649147184</stembedurl><a href="https://stocktwits.com/symbol/NKE">NKE stock</a> is down 17% year-to-date. The S&amp;P 500 ETF Trust (SPY) is up 16% over the past 12 months, while the Vanguard Total Stock Market Index Fund ETF (VTI) is up 17%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ipm-bcg-hubc-stocks-top-premarket-gainers-april-1-2026/cZ7H1jsRInn">IPM, BCG, HUBC Among Stocks Soaring Before The Bell — Top Pre-Market Gainers Today</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A Nike store with its swoosh logo prominently displayed on the glass storefront is seen inside a shopping mall on February 22, 2025, in Chongqing, China. (Photo by Cheng Xin/Getty Images)

Nike’s China Bet Is Under Pressure And Wall Street Is Losing Confidence – Analysts Warn Return To Growth Could Take 4 Quarters

Nike expects fourth-quarter revenue to decline between 2% and 4% year-on-year, implying a range of $10.66 billion and $10.88 billion, which is lower than the consensus estimate of $11.3 billion.

NKE Stock Gets Hit With Downgrades As China Slump Clouds Turnaround 

<ul class="summary-bullets"><li>An exposure-response analysis showed a statistically significant link between higher drug exposure and increased toxicities as well as more frequent treatment interruptions and discontinuations, the company said.</li><li>ORIC said it plans to launch its global late stage trial in metastatic castration-resistant prostate cancer patients who were previously treated with abiraterone using the 400 mg dose in the first half of 2026.</li></ul>Shares of ORIC Pharmaceuticals, Inc. (ORIC) fell 25% after hours on Tuesday after the company announced that it has selected a 400 mg once-daily dose of its investigational drug for a later stage trial after tolerability concerns emerged during an early stage study.In the early-stage trial involving certain previously treated patients with metastatic castration-resistant prostate cancer, the higher 600 mg dose of rinzimetostat produced a “modestly higher rate of adverse events and dose modifications” compared with the 400 mg level when administered with darolutamide, the company said.An exposure-response analysis showed a statistically significant link between higher drug exposure and increased toxicities as well as more frequent treatment interruptions and discontinuations, favoring the lower dose on safety grounds, it added.At the selected 400 mg dose, a grade 3 treatment-related adverse event was observed though the majority were mild, Oric said. Grade 3 treatment-related adverse events are severe, significant toxicities that are not immediately life-threatening. The company also reported one discontinuation in the early-stage &nbsp;trial. However, the company CEO Jacob M. Chacko said that the drug demonstrated a "cleaner safety profile than competitor regimens."ORIC said it plans to launch its global late stage trial in metastatic castration-resistant prostate cancer patients who were previously treated with abiraterone using the 400 mg dose in the first half of 2026. &nbsp;“Early efficacy data… are suggestive of meaningful and durable clinical benefit for rinzimetostat in combination with darolutamide compared to competitor data and historical outcomes with approved therapies,” the company said.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around ORIC stock jumped from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume jumped from ‘normal’ to ‘extremely high’ levels.<a href="https://stocktwits.com/symbol/ORIC">ORIC stock </a>has gained 127% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/omer-stock-surges-after-hours-on-novo-nordisk-deal-windfall-drug-launch-optimism/cZE5fIyRIVy">OMER Stock Surges 5% After Hours On Novo Nordisk Deal Windfall And Drug Launch Optimism</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Oric Pharmaceuticals logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

ORIC Falls After Hours On Safety Concerns Around Prostate Cancer Candidate At Higher Doses

The company noted that a higher dose of its experimental cancer drug was associated with a higher rate of adverse events in an early-stage trial. 

<ul class="summary-bullets"><li>The company said that its fourth quarter results include a net gain of $237.6 million tied to the zaltenibart transaction with Novo Nordisk.</li><li>The company’s Yartemlea was approved by the U.S. Food and Drug Administration for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy in December.</li><li>The company is now looking forward to an approval for the therapy from the European Medicines Agency by mid-2026.</li></ul>Shares of Omeros Corporation (OMER) rose 5% after hours on Tuesday after the company expressed optimism for its deal with Danish drugmaker Novo Nordisk and regarding its other drugs.The company reported net income for the fourth quarter of $86.5 million, compared to a net loss of $31.4 million in the corresponding quarter of 2024.<h2 class="st-heading-2">Omeros Corp Deal With Novo</h2>The company said that its fourth quarter results include a net gain of $237.6 million tied to the zaltenibart transaction with Novo Nordisk. Under the deal valued up to $2.1 billion, the Danish drugmaker received exclusive global rights in all indications to develop and commercialize Omeros’s zaltenibart and certain related antibodies and products.The transaction was closed in November, triggering an upfront cash payment of $240 million. The company is now eligible to receive milestone payments and tiered royalties on annual global net sales of applicable products. &nbsp;<h2 class="st-heading-2">Remaining Lineup</h2>The company’s Yartemlea was approved by the U.S. Food and Drug Administration for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy in adults and in children ages two years and older in December. Commercial distribution and sales of Yartemlea in the U.S. began in January. The drug is now being prescribed to both adult and pediatric patients across both hospital and outpatient settings, the company said, while adding that it has engaged several of its workforce to engage directly with transplant centers across the United States.The company is now looking forward to an approval for the therapy from the European Medicine Agency by mid-2026.“Following FDA approval of Yartemlea with a broad label and no boxed warning, REMS, or required vaccinations, our commercial launch is well underway, and patients who urgently need the drug are now able to access it,” said Omeros CEO Gregory A. Demopulos. “Our partnership with Novo Nordisk expands the breadth of indications being pursued for zaltenibart and has provided — and should continue to provide — substantial operating capital... These successes are expected to fuel the development of a growing portfolio of commercial products from our robust pipeline as we target positive cash flow in 2027.”<h2 class="st-heading-2">How Omeros Corp Retail Traders React?</h2>On Stocktwits, retail sentiment around OMER stock jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.A Stocktwits user expressed optimism for the stock rallying on the next trading day.<stembedurl>https://www.stocktwits.com/Discovergems/message/649116149</stembedurl>Another user expressed optimism for Yartemlea, particularly if it gets approval in the EU.<stembedurl>https://www.stocktwits.com/AgentMulder/message/649115278</stembedurl><a href="https://stocktwits.com/symbol/OMER">OMER stock</a> has gained 28% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/mltx-stock-garners-retail-attention-on-buyout-speculation-positive-skin-condition-trial-data/cZE5EhaRIVu">MLTX Stock Garners Retail Attention On Buyout Speculation, Positive Skin Condition Trial Data</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Omeros Corporation logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

OMER Stock Surges 5% After Hours On Novo Nordisk Deal Windfall And Drug Launch Optimism

Omeros reported net income for the fourth quarter of $86.5 million, compared to a net loss of $31.4 million in the corresponding quarter of 2024.

<ul class="summary-bullets"><li>The company’s troubles continue in its Greater China market, where revenue fell 7% to $1.62 billion.</li><li>Nike said on Tuesday that it ended the quarter with $8.49 billion in inventory, down 1% from the corresponding quarter last fiscal year.</li><li>Nike is currently in the middle of a multi-year turnaround strategy led by CEO Elliott Hill, who took over in late 2024 to reverse a period of slowing sales and lost market share.</li></ul>Shares of sneaker giant Nike Inc (NKE) fell 9% after hours on Tuesday after the company recorded a drop in third quarter (Q3) gross profit margin amid tariff-related uncertainty and put forth weak fourth quarter revenue outlook. &nbsp;The company’s third quarter earnings and revenue beat Wall Street expectations. While diluted earnings per share for the period came in at $0.35, above an analyst estimate of $0.28, revenue came in at $11.28 billion, flat year-over-year but above the $11.22 billion expected by analysts.The company’s troubles continue in its Greater China market, where revenue fell 7% to $1.62 billion. However, the company clocked growth in its home market in North America as revenue climbed 3% to $5.03 billion.Nike’s gross profit margin slid 130 basis points to 40.2%, primarily owing to higher tariffs in North America. &nbsp;Nike is currently in the middle of a multi-year turnaround strategy led by CEO Elliott Hill, who took over in late 2024 to reverse a period of slowing sales and lost market share. The turnaround involves repairing relations with retailers after a former direct-to-consumer push and cleaning up excess inventory, among other measures.Nike said on Tuesday that it ended the quarter with $8.49 billion in inventory, down 1% from the corresponding quarter last fiscal year primarily reflecting a decrease in units and product mix shifts but partially offset by increased product costs, primarily due to Trump’s tariffs.<h2 class="st-heading-2">Q4 Outlook of Nike</h2>The company now expects fourth quarter revenue to be down 2%-4%, owing to declines in Greater China and Converse brand revenues.For the remaining calendar year, the company expects revenues to be down “low single digits” versus the prior year, with gains in North America offset by declines in Greater China.“We expect the first quarter of fiscal 2027 to be the final quarter where higher tariffs continue to be a material year-over-year headwind to gross margin,” Nike CFO Matt Friend said while also warning that the company’s guidance presupposes that the geopolitical situation remains as is.“...the environment around us has become increasingly dynamic, and we could experience unplanned volatility due to the disruption in the Middle East, rising oil prices, and other factors that could impact either input costs or consumer behavior. We are focused on what we can control, and these assumptions reflect the macro environment as it stands today,” he added.<h2 class="st-heading-2">Hill’s Turnaround Efforts</h2>In October, Hill highlighted the complexity involved in turning around the fortunes of a company like Nike.“It’s gonna take a while. It’s not linear. But it is a portfolio, and ultimately the goal is to have the entire portfolio all working together to drive the revenue and the profit that we hope to deliver for all of our investors,” Hill said in an interview.Hill reiterated the opinion on Tuesday and said, “"This quarter we took meaningful actions to improve the health and quality of our business. The pace of progress is different across the portfolio and the areas we prioritized first continue to drive momentum.”<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around NKE stock rose from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.<a href="https://stocktwits.com/symbol/NKE">NKE stock</a> has lost 17% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/alks-stock-surges-on-lilly-centessa-buyout-igniting-sleep-pipeline-hopes/cZE55YcRIVr">ALKS Stock Surges 15% On Lilly-Centessa Buyout Igniting Sleep Pipeline Hopes</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A detailed view as British marathon runner Charlotte Purdue changes her Nike trainers during a training session on June 29, 2020 in East Molesey, England.

Nike Edges Lower Despite Q3 Win Amid Tariff-Related Worries, Weak Q4 Guidance

Nike is currently in the middle of a multi-year turnaround strategy led by CEO Elliott Hill, who took over in late 2024 to reverse a period of slowing sales and lost market share.

Q3 diluted earnings per share came in at $0.35, above an analyst estimate of $0.28. 


<ul class="summary-bullets"><li>The agency concluded that the drivers’ overreliance on the automated system contributed to both crashes.</li><li>Following the probe, the agency called for standardized performance requirements for automated vehicle tech while noting that there are several gaps in oversight at present.</li><li>The probe also highlighted issues with Ford’s BlueCruise implementation, noting that the drivers can disengage Ford’s automatic emergency braking system when using it.</li></ul> The National Transportation Safety Board on Tuesday called for greater oversight on automated vehicle technology technology on the heels of two fatal Ford crashes.The agency said that it investigated two crashes involving Ford’s partial automation system BlueCruise and concluded that the drivers’ overreliance on the automated system contributed to both crashes. In the crashes that occurred in 2024, BlueCruise failed to stop for stationary vehicles, it said.Ford shares edges about 1% lower after hours at the time of writing.<h2 class="st-heading-2">Probe Takeaways</h2>Following the probe, the agency called for standardized performance requirements for automated vehicle tech while noting that there are several gaps in oversight at present. The probe also highlighted issues with Ford’s BlueCruise implementation, noting that the drivers can disengage Ford’s automatic emergency braking system when using it.The NTSB has issued recommendations to the U.S. Department of Transportation, as well as Ford, calling for crash data recording and automatic crash notification requirements, improved driver monitoring systems to detect distraction, and changes to Ford’s BlueCruise system to reduce excessive speeding.“This investigation highlights the urgent need for stronger safety standards and better oversight of automated driving systems,” said NTSB chairwoman Jennifer Homendy. “Manufacturers and federal regulators must ensure these technologies are designed, monitored and implemented in ways that keep all our road users safe. We cannot take a ‘hands off’ approach to hands-free driving technology. Lives depend on it.”<h2 class="st-heading-2">The Accidents</h2>NTSB said that one of the crashes occurred in San Antonio in Feb. 2024. A Ford traveling east in the center lane of Interstate 10 struck a stationary 1999 Honda CR-V, killing the Honda driver while the Ford driver sustained minor injuries.In the second crash that occurred in Philadelphia in March 2024, the &nbsp;Ford traveling north in the left lane of Interstate 95 struck two stationary vehicles—a 2012 Hyundai Elantra and a 2006 Toyota Prius—causing them to collide with a passing Toyota Corolla. The driver of the Prius and Elantra were both killed while the Corolla driver was uninjured.In both the incidents, no driver-applied or system-initiated braking or steering was recorded in the moments before the crash, NTSB said.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around Ford stock stayed within the ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.<a href="https://stocktwits.com/symbol/F">F stock</a> has gained 15% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/omer-stock-surges-after-hours-on-novo-nordisk-deal-windfall-drug-launch-optimism/cZE5fIyRIVy">OMER Stock Surges 5% After Hours On Novo Nordisk Deal Windfall And Drug Launch Optimism</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Ford exhibit area is shown at the 2025 Detroit Auto Show at Huntington Place on January 10, 2025 in Detroit, Michigan. 

Ford Stock Dips After Hours As NTSB Blames Overreliance On Automated Tech For Fatal Crashes

In the crashes that occurred in 2024, BlueCruise failed to stop for stationary vehicles, the agency said.

Big Tech's $635B AI Push Meets Energy Crunch: ETFs to Diversify 

Rising oil prices threaten to derail Big Tech's massive AI push. Staying diversified with ETFs may be the smartest long-term move.

<ul class="summary-bullets"><li>BlackSky stated that this contract is aimed at helping with the design and development of next-generation space intelligence.</li><li>CEO Brian O’Toole noted that these developments will enable ultra-high-resolution imaging, enhanced collection performance, and low-latency space-based communications.</li><li>BlackSky said the satellites will serve multiple roles, including acting as data storage and processing hubs and integrating with on-orbit data centers.</li></ul>BlackSky Technology Inc. (BKSY) on Tuesday announced that it has won a U.S. government contract for designing technology for Earth observation.The company stated that the contract’s value is $99 million, slightly lower than BlackSky’s full-year 2025 revenue of $107 million. BlackSky also added that it has already received an initial payment of $2 million.<a href="https://stocktwits.com/symbol/BKSY">BlackSky shares</a> were up nearly 9% in Tuesday morning’s trade. Retail sentiment on Stocktwits around the company trended in the ‘bullish’ territory at the time of writing, with message volumes at ‘extremely high’ levels.<h2 class="st-heading-2">Developing Next-Gen Space Intelligence</h2>BlackSky stated that this contract is aimed at helping with the design and development of next-generation space intelligence. It added that the capabilities and mission applications this project addresses are distinct from those addressed by current Gen-2 and Gen-3 monitoring systems and the company’s future AROS broad-area search system.“We will leverage the unique, highly scalable core technology of Gen-3 into every incremental advancement along our roadmap, looking at the AROS broad area search system as the next step into the more expansive very large-aperture optical imagery capabilities covered by this contract,” said BlackSky CEO Brian O’Toole.He added that these developments will enable ultra-high-resolution imaging, enhanced collection performance, and low-latency space-based communications.The company expects the contract to enable expanded applications in high-cadence Earth monitoring and tracking objects across low Earth, geostationary, and cis-lunar orbits.<h2 class="st-heading-2">Satellites With Multi-Role Capabilities</h2>BlackSky noted that the satellites that will be developed under this contract will serve multiple roles. This includes operating as a data storage and processing hub and being compatible with on-orbit data centers.The company noted that this is an indefinite-delivery, indefinite-quantity contract for a multi-year period.BlackSky is a Herndon, Virginia-based company that provides real-time space intelligence with on-demand imagery, analytics, and high-frequency monitoring of critical global assets and events.<a href="https://stocktwits.com/symbol/BKSY">BKSY stock</a> is up 24% year-to-date and 202% over the past 12 months. The Vanguard Total Stock Market Index Fund ETF (VTI) is up 15% over the past 12 months, while the iShares Russell 2000 ETF (IWM) is up 22%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/warren-buffett-sold-apple-shares-too-soon-berkshire/cZEPvVFRIVi">Buffett Says He Sold Apple Shares Too Soon, But Does Not Regret It: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the BlackSky Technology logo is seen displayed on a smartphone screen.

BKSY Stock Is Rising Today – This Government Deal Could Be A Turning Point

BlackSky Technology (BKSY) stated that the contract’s value is $99 million, slightly lower than BlackSky’s full-year 2025 revenue of $107 million.

The company stated that the contract’s value is $99 million, slightly lower than BlackSky’s full-year 2025 revenue of $107 million.

<ul><li>The judge also said that the motion for her recusal “rests on a false premise.”</li><li>According to a report from Reuters, Tesla shareholder David Wagner dismissed his 2022 case against the Tesla board after McCormick posted the letter.</li><li>Musk has attacked McCormick several times since she ruled against his 2018 pay package &nbsp;stating that the company's board breached their fiduciary duties to shareholders by approving it.</li></ul> Chancellor Kathaleen McCormick of the Court of Chancery said on Monday that she will reassign three cases against Tesla CEO Elon Musk and its board members following allegations that she supported a social media post which raises questions of bias.McCormick said in a letter addressed to legal teams involved in three lawsuits that she is not biased against Musk, while noting that she dismissed a suit against the billionaire last year. She also <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://t.co/h8ObdXaHh4">said</a> that the motion for her recusal “rests on a false premise.” Tesla had pushed for her recusal based on a screenshot of the judge’s support for a Linkedin post that congratulated the legal teams which led a separate federal securities fraud case against ​Musk.“...disproportionate media attention surrounding a judge’s handling of an action is detrimental to the administration of justice. &nbsp;Fortunately, the Court of Chancery is far greater than any one person,” the judge said in a letter. She also called upon the legal teams who sought the change to contact her Chambers and obtain a time for a random reassignment of the cases.<h2 class="st-heading-2">Shareholder Dismisses Case</h2>According to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/sustainability/boards-policy-regulation/delaware-judge-accused-bias-reassigns-musk-cases-2026-03-30/">report</a> from Reuters, Tesla shareholder David Wagner dismissed his 2022 case against the Tesla board after McCormick posted the letter. His was one of the three cases that the judge had chosen to reassign.<h2 class="st-heading-2">McCormick Vs. Musk</h2>Musk has attacked McCormick several times since she ruled against his 2018 pay package &nbsp;stating that the company's board breached their fiduciary duties to shareholders by approving it. The Delaware Supreme Court reinstated the package in December 2025.Musk has since then moved Tesla's state of incorporation out of Delaware and into Texas. He also called on other companies to follow suit, and accused the judge of activism and absolute corruption.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around TSLA stock fell from ‘bearish’ to ‘extremely bearish’ territory over the past 24 hours while message volume stayed at ‘high’ levels.<a href="https://stocktwits.com/symbol/TSLA">TSLA stock</a> has gained 37% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/vktx-vs-gpcr-which-obesity-drug-developer-does-wall-street-see-with-bigger-upside/cZETcp3RINo">VKTX Vs. GPCR: Which Obesity Drug Developer Does Wall Street See With The Bigger Upside?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Elon Musk pictured in the Oval Office at the White House on May 21, 2025. (Photo by Chip Somodevilla/Getty Images)

Tesla Scores Court Reassignment in Musk Cases as Judge Blasts Bias Motion

McCormick said in a letter addressed to legal teams involved in three lawsuits that she is not biased against Musk, while noting that she dismissed a suit against the billionaire last year.

Vanguard Index Funds - Vanguard Total Stock Market ETF

Thematic ETFs

Prediction Markets

OpenClaw & Agentic-Directed Trading

Tokenization

Recognizing the tool or mechanism that redefined how we trade. From prediction markets to next-gen tech, this award honors the innovation that pushed the boundaries of access and efficiency in modern finance.

VTI
Vanguard Total Stock Market ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest VTI News

VTIVanguard Total Stock Market ETF